Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Colin E Fowler

4PUBLICATIONS
15CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Feb 12, 2026
PRMT5 inhibitors actively promote metastatic progression of lung adenocarcinoma.

Colin E Fowler, Natalie A O'Hearn, Nicole Henning

|Jan 07, 2025
The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing.

Colin E Fowler, Natalie A O'Hearn, Griffin J Salus

|Aug 19, 2021
Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel.

Helen S Mueller, Colin E Fowler, Simona Dalin

|Nov 30, 2018
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells.

Sean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan

Pageof 1

Frequent Collaborators

1 joint publications

Sean W Fanning

1 joint publications

Christopher G Mayne

1 joint publications

Jerome C Nwachukwu

1 joint publications

Sarat Chandarlapaty

1 joint publications

Emad Tajkhorshid

1 joint publications

Patrick R Griffin

1 joint publications

Yang Shen

1 joint publications

John A Katzenellenbogen

1 joint publications

Myles Brown

1 joint publications

Geoffrey L Greene

Frequent Collaborators

1 joint publications

Sean W Fanning

1 joint publications

Christopher G Mayne

1 joint publications

Jerome C Nwachukwu

1 joint publications

Sarat Chandarlapaty

Top Related Videos

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities
05:11

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities

Published on : May 10, 2024

1.9K
ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast
07:31

ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast

Published on : Jun 30, 2022

2.4K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.6K
See more related videos

Top Related Videos

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities
05:11

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities

Published on : May 10, 2024

1.9K
ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast
07:31

ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast

Published on : Jun 30, 2022

2.4K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.6K
See more related videos